Cargando…
Small Cell Carcinoma of the Esophagus: A Nationwide Analysis of Treatment and Outcome at Patient Level in Locoregional Disease
BACKGROUND AND PURPOSE: Small cell carcinoma of the esophagus (SCEC) is a rare subtype of esophageal cancer for which optimal treatment is unknown. We analyzed the impact of treatment factors on outcome in patients with nonmetastasized SCEC. METHODS: Patients with a histologically confirmed SCEC wit...
Autores principales: | Jeene, Paul M., Geijsen, Elisabeth D., Muijs, Christina T., Rozema, Tom, Aleman, Berthe M.P., Muller, Karin, Baas, Jara M., Nuyttens, Joost J., Wouterse, Sanne, Braam, Pètra M., Oppedijk, Vera, Ceha, Heleen M., Cnossen, Jeltsje, Spruit, Patty, Bongers, Eva M., Berbée, Maaike, Mook, Stella, Hulshof, Maarten C.C.M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554014/ https://www.ncbi.nlm.nih.gov/pubmed/31021827 http://dx.doi.org/10.1097/COC.0000000000000546 |
Ejemplares similares
-
Treatment patterns and survival in advanced unresectable esophageal squamous cell cancer: A population‐based study
por: Pape, Marieke, et al.
Publicado: (2022) -
Acute toxicity of definitive chemoradiation in patients with inoperable or irresectable esophageal carcinoma
por: Haj Mohammad, Nadia, et al.
Publicado: (2014) -
Locoregional control and survival after lymph node SBRT in oligometastatic disease
por: Loi, Mauro, et al.
Publicado: (2018) -
Decision consultations on preoperative radiotherapy for rectal cancer: large variation in benefits and harms that are addressed
por: Kunneman, M, et al.
Publicado: (2015) -
Radiotherapy is the Preferred Primary Tumor Treatment in Oligometastatic Prostate Cancer
por: van Moorselaar, R. Jeroen A., et al.
Publicado: (2022)